Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)

4.48
Delayed Data
As of Sep 20
 +0.69 / +18.21%
Today’s Change
2.42
Today|||52-Week Range
6.10
+55.56%
Year-to-Date
No recent news for Dicerna Pharmaceuticals Inc.

Today’s Trading

Previous close3.79
Today’s open4.00
Day’s range3.96 - 4.74
Volume1,258,165
Average volume (3 months)121,112
Market cap$79.0M
Dividend yield--
Data as of 09/20/2017

Growth & Valuation

Earnings growth (last year)+7.12%
Earnings growth (this year)-3.41%
Earnings growth (next 5 years)--
Revenue growth (last year)+60.33%
P/E ratioNM
Price/Sales202.28
Price/Book1.91

Competitors

 Today’s
change
Today’s
% change
ARLZAralez Pharmaceutica...+0.01+0.70%
NOVNNovan Inc+0.07+1.25%
ARQLArQule Inc-0.01-0.86%
MRNSMarinus Pharmaceutic...-0.15-3.48%
Data as of 09/20/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.75
Annual revenue (last year)$295.0K
Annual profit (last year)-$59.5M
Net profit margin-20,173.90%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Douglas M. Fambrough
Senior Vice President-
Operations
David W. Miller
Corporate headquarters
Cambridge, Massachusetts

Forecasts